FDA cleared the EsTemp Implant from Spident Co., Ltd. on Sep 25, 2026 under K262983, a special 510(k). The device falls under product code EMA, Cement, Dental, regulated at 21 CFR 872.3275 as a Class 2 device. The review panel was Dental.
FDA logged the submission as received on Aug 27, 2026. The decision came 29 days later, inside the 90 FDA-day goal for a 510(k).
Spident Co., Ltd. has 3 other decisions in the tracker over the last 12 months: K262982 (Core·it Dual), K262050 (Vioseal X), K261129 (OrthoFit).